Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone - thyrotropin alfa)

Authors

  • Marta E Gonzalez
  • Thomas Jose Eluvathingal Muttikkal
  • Patrice K Rehm

DOI:

https://doi.org/10.3941/jrcr.v9i6.2220

Keywords:

Iodine-131, Thyrogen, diagnostic, salivary glands, sialadenitis

Abstract

Salivary dysfunction and sialadenitis are well known complications of radioiodine treatment for thyroid cancer.  The parotid gland is more frequently affected and the salivary gland injury is dose related. The symptoms may develop shortly after therapeutic Iodine 131(I-131) administration or months later and progress with time. The development of unilateral parotiditis following a low dose, diagnostic I-131 scan performed following Thyrogen stimulation in a patient without prior history of sialadenitis is rare in our experience, and has not been reported in the medical literature.

Author Biographies

Marta E Gonzalez

Department of Radiology and Medical Imaging University of Virginia. Currently at ONRAD, California  based at ENMMC and at Teleradiology Specialists

Thomas Jose Eluvathingal Muttikkal

Department of Radiology and Medical Imaging University of Virginia

Patrice K Rehm

Department of Radiology and Medical Imaging

Published

2015-06-10

Issue

Section

Nuclear Medicine / Molecular Imaging